Almost a quarter of new psychosis cases linked to strong 'skunk like' cannabis
People who smoke super-strength cannabis every day are five times more likely to develop psychosis than people who have never tried the drug
Your support helps us to tell the story
This election is still a dead heat, according to most polls. In a fight with such wafer-thin margins, we need reporters on the ground talking to the people Trump and Harris are courting. Your support allows us to keep sending journalists to the story.
The Independent is trusted by 27 million Americans from across the entire political spectrum every month. Unlike many other quality news outlets, we choose not to lock you out of our reporting and analysis with paywalls. But quality journalism must still be paid for.
Help us keep bring these critical stories to light. Your support makes all the difference.
Nearly a quarter of new cases of psychosis are linked to high-potency “skunk like” cannabis, new research shows.
People who smoke super-strength cannabis are three times more likely to develop psychosis than people who have never tried the drug – and five times more likely if they smoke it every day.
The study, by researchers at King’s College London, will fuel calls for politicians and public health officials to take a stronger stance against high potency cannabis, at a time when many campaigners are arguing for marijuana to be legalised. The researchers say there is an “urgent need” to inform young people about the risks of strong cannabis.
Uruguay and the US state of Colorado have legalised cannabis use in recent years, but there is mounting evidence that strong types of the drug can trigger mental illness.
“This paper suggests that we could prevent almost one quarter of cases of psychosis if no-one smoked high potency cannabis. This could save young patients a lot of suffering and the NHS a lot of money,” said Sir Robin Murray, Professor of Psychiatric Research at Institute of Psychiatry, Psychology & Neuroscience at King’s, which carried out the research.
Dr Marta Di Forti from the IoPPN, who was lead author on the research, said GPs should ask their patients what type of cannabis they smoke, to clarify the risk of psychosis. The study found that smoking hash, a less potent form of cannabis, had no association with psychosis.
The research is published in Lancet Psychiatry.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments